PRGO - Perrigo Company PLC - Stock Price & Dividends
Exchange: USA Stocks • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00BGH1M568
Medicines, Vitamins, Supplements, Oral Care, Skin Care, Nutrition
Perrigo Company plc is a leading provider of over-the-counter (OTC) health and wellness solutions, dedicated to enhancing individual well-being globally. The company operates through two primary segments: Consumer Self-Care Americas and Consumer Self-Care International.
Through its comprehensive product portfolio, Perrigo develops, manufactures, markets, and distributes a wide range of self-care consumer products. These include upper respiratory products, such as cough suppressants and sinus relief medications; nutrition products, including infant formulas and nutritional beverages; and digestive health products, like antacids and anti-diarrheal medications.
In addition, the company offers pain and sleep-aids products, comprising pain relievers and fever reducers; oral care products, including toothbrushes, floss, and whitening products; and healthy lifestyle products, such as smoking cessation and weight management products. Perrigo also provides skin care products, women's health products, vitamins, minerals, and supplements, as well as rare diseases business and other miscellaneous self-care products.
Perrigo's products are sold under a diverse range of brands, including Compeed, Dr. Fresh, Firefly, Good Sense, and many more. The company's contract manufacturing services enable it to cater to a broad customer base. Perrigo's products are available through various channels, including retail drug stores, supermarkets, mass merchandise chains, e-commerce platforms, wholesalers, pharmacies, drug and grocery retailers, and para-pharmacies.
With a rich history dating back to 1887, Perrigo Company plc is headquartered in Dublin, Ireland, and has undergone significant transformations, including a name change in December 2013. Today, the company remains committed to providing high-quality, affordable healthcare solutions to people around the world.
Drawdown (Underwater) Chart
PRGO Stock Overview
Market Cap in USD | 3,337m |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
GiC SubIndustry | Pharmaceuticals |
TER | 0.00% |
IPO / Inception | 1991-12-16 |
PRGO Stock Ratings
Growth 5y | -60.5 |
Fundamental | -24.1 |
Dividend | 65.9 |
Rel. Performance vs Sector | -2.72 |
Analysts | 4.17/5 |
Fair Price Momentum | 22.78 USD |
Fair Price DCF | 41.93 USD |
PRGO Dividends
Dividend Yield 12m | 4.26% |
Yield on Cost 5y | 2.34% |
Dividends CAGR 5y | 5.90% |
Payout Consistency | 100.0% |
PRGO Growth Ratios
Growth 12m | -7.65% |
Growth Correlation 12m | -53.2% |
Growth Correlation 3m | -64.9% |
CAGR 5y | -11.32% |
CAGR/Mean DD 5y | -0.37 |
Sharpe Ratio 12m | -0.36 |
Alpha vs SP500 12m | -32.70 |
Beta vs SP500 5y weekly | 0.57 |
ValueRay RSI | 59.94 |
Volatility GJR Garch 1y | 28.26% |
Price / SMA 50 | -3.11% |
Price / SMA 200 | -9.58% |
Current Volume | 3071.9k |
Average Volume 20d | 1542.7k |
External Links for PRGO Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 22, 2024, the stock is trading at USD 25.85 with a total of 3,071,913 shares traded.
Over the past week, the price has changed by +6.91%, over one month by -4.72%, over three months by -5.95% and over the past year by -8.25%.
According to ValueRays Forecast Model, PRGO Perrigo Company PLC will be worth about 24.6 in October 2025. The stock is currently trading at 25.85. This means that the stock has a potential downside of -4.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 35.7 | 38.0 |
Analysts Target Price | 49 | 89.6 |
ValueRay Target Price | 24.6 | -4.84 |